These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22721537)

  • 1. Cost and benefits of implementing an occupational safety and health management system (OSH MS) in enterprises in Poland.
    Rzepecki J
    Int J Occup Saf Ergon; 2012; 18(2):181-93. PubMed ID: 22721537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workers' involvement--a missing component in the implementation of occupational safety and health management systems in enterprises.
    Podgórski D
    Int J Occup Saf Ergon; 2005; 11(3):219-31. PubMed ID: 16216138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Models of economic evaluation of health and safety interventions at workplace].
    Rydlewska-Liszkowska I
    Med Pr; 2005; 56(5):411-8. PubMed ID: 16483013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupational safety and health as an element of a complex compensation system evaluation within an organization.
    Beck-Krala E; Klimkiewicz K
    Int J Occup Saf Ergon; 2016 Dec; 22(4):523-531. PubMed ID: 27191788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poland in transition to the European union (in the context of meeting standards in occupational safety and health).
    Koradecka D
    Int J Occup Saf Ergon; 2001; 7(4):463-79. PubMed ID: 11743908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of tacit knowledge in occupational safety and health management systems.
    Podgórski D
    Int J Occup Saf Ergon; 2010; 16(3):283-310. PubMed ID: 20828486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of cost estimation tools for total occupational safety and health activities and occupational health services: cost estimation from a corporate perspective.
    Nagata T; Mori K; Aratake Y; Ide H; Ishida H; Nobori J; Kojima R; Odagami K; Kato A; Tsutsumi A; Matsuda S
    J Occup Health; 2014; 56(3):215-24. PubMed ID: 24739371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to measure efficiency of health investments in enterprises: selected issues].
    Rydlewska-Liszkowska I
    Med Pr; 2005; 56(6):467-74. PubMed ID: 16613372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utilization, needs, and related factors for e-learning and its application to education and training in occupational safety and health among enterprises in Japan].
    Mitsuhashi T; Takao S; Tsutsumi A; Kawakami N
    Sangyo Eiseigaku Zasshi; 2006 Sep; 48(5):183-91. PubMed ID: 17062998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Transition from Occupational Safety and Health (OSH) Interventions to OSH Outcomes: An Empirical Analysis of Mechanisms and Contextual Factors within Small and Medium-Sized Enterprises.
    Micheli GJL; Cagno E; Calabrese A
    Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30065234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [National survey on workplace safety and prevention services: regional differences].
    Martini A; Bonafede M; Buresti G; Bertazzi PA; Di Leone G; Isolani L; Corso L; Iavicoli S
    Med Lav; 2016 Sep; 107(5):389-398. PubMed ID: 27681570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational health and safety management in polish enterprises implementing total quality management systems.
    Podgórski D
    Int J Occup Saf Ergon; 2000; Spec No():85-101. PubMed ID: 10828155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of investment in occupational health and safety in Colombian companies.
    Riaño-Casallas MI; Tompa E
    Am J Ind Med; 2018 Nov; 61(11):893-900. PubMed ID: 30284313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Occupational exposure to biological agents intentionally used in Polish enterprises].
    Kozajda A; Szadkowska-Stańczyk I
    Med Pr; 2015; 66(1):39-47. PubMed ID: 26016044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational safety and health performance indicators in SMEs: A literature review.
    Barbosa C; Azevedo R; Rodrigues MA
    Work; 2019; 64(2):217-227. PubMed ID: 31524191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Talk and Safety Culture: Discursive Repertoires as Indicators of Workplace Safety and Health Practice and Readiness to Change.
    Cunningham TR; Jacobson CJ
    Ann Work Expo Health; 2018 Sep; 62(suppl_1):S55-S64. PubMed ID: 30212880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs and benefits of medical prevention in small enterprises].
    Rydlewska-Liszkowska I; Jugo B; Kacprzak E
    Med Pr; 1997; 48(6):717-25. PubMed ID: 9558640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational safety and health in Japan: current situations and the future.
    Sakurai H
    Ind Health; 2012; 50(4):253-60. PubMed ID: 22878266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of occupational diseases and accidents at work in Poland].
    Rydlewska-Liszkowska I
    Med Pr; 2006; 57(4):317-24. PubMed ID: 17133912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing, implementing and evaluating OSH interventions in SMEs: a pilot, exploratory study.
    Masi D; Cagno E; Micheli GJ
    Int J Occup Saf Ergon; 2014; 20(3):385-405. PubMed ID: 25189744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.